懷特生技新藥股份有限公司
懷特生技新藥股份有限公司（PhytoHealth Corporation）研發、製造銷售中藥材與新藥、醫學影像及精密醫療儀器。產品包括用於癌症疲憊症的黃耆多醣注射液。研發管線涵蓋骨質疏鬆與糖尿病藥物。公司成立於 1998 年，總部位於台灣台北。
今日下跌 1.72%。該股 RSI(6) 為 52.7，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、20日均線，跌破60日、120日均線。KD 指標中性（K=57.5）；MACD 柱狀體為正值，維持多方動能。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 09-24 | -15 | 0 | 0 | -15 |
| 09-23 | -8 | 0 | -3 | -11 |
| 09-22 | +18 | 0 | 0 | +18 |
| 09-21 | -42 | 0 | +4 | -38 |
| 09-18 | +20 | 0 | +2 | +22 |
| 09-17 | -8 | 0 | -3 | -11 |
| 09-16 | +6 | 0 | +3 | +9 |
| 09-15 | -1 | 0 | +2 | +1 |
| 09-14 | -6 | 0 | -3 | -9 |
| 09-11 | -54 | 0 | +2 | -52 |
| 09-10 | -1 | 0 | 0 | -1 |
| 09-09 | +15 | 0 | 0 | +15 |
| 09-08 | +12 | 0 | 0 | +12 |
| 09-07 | -2 | 0 | 0 | -2 |
| 09-04 | +8 | 0 | 0 | +8 |
| 09-03 | +2 | 0 | 0 | +2 |
| 09-02 | +20 | 0 | 0 | +20 |
| 09-01 | +14 | 0 | 0 | +14 |
| 08-31 | -9 | 0 | -2 | -11 |
| 08-28 | -22 | 0 | +2 | -20 |
| 08-27 | +14 | 0 | +1 | +15 |
| 08-26 | +53 | 0 | +2 | +55 |
| 08-25 | -29 | 0 | 0 | -29 |
| 08-24 | -11 | 0 | +3 | -8 |
| 08-21 | +53 | 0 | -2 | +51 |
| 08-20 | +30 | 0 | 0 | +30 |
| 08-19 | -8 | 0 | 0 | -8 |
| 08-18 | -8 | 0 | 0 | -8 |
| 08-17 | -6 | 0 | +2 | -4 |
| 08-14 | -3 | 0 | -1 | -4 |
| 08-13 | +15 | 0 | -2 | +13 |
| 08-12 | +29 | 0 | +2 | +31 |
| 08-11 | -2 | 0 | -1 | -3 |
| 08-10 | +8 | 0 | +1 | +9 |
| 08-07 | 0 | 0 | -1 | -1 |
| 08-06 | -23 | 0 | -1 | -24 |
| 08-05 | -36 | 0 | 0 | -36 |
| 08-04 | +25 | 0 | -4 | +21 |
| 08-03 | -4 | 0 | -3 | -7 |
| 07-31 | -11 | 0 | +1 | -10 |
| 07-30 | -24 | 0 | -3 | -27 |
| 07-29 | +60 | 0 | +4 | +64 |
| 07-28 | -39 | 0 | -2 | -41 |
| 07-27 | +2 | 0 | +2 | +4 |
| 07-24 | -1 | 0 | -2 | -3 |
| 07-23 | -21 | 0 | +2 | -19 |
| 07-22 | -11 | 0 | -2 | -13 |
| 07-21 | +6 | 0 | -1 | +5 |
| 07-20 | +88 | 0 | +2 | +90 |
| 07-17 | +43 | 0 | +3 | +46 |
| 07-16 | +14 | 0 | +1 | +15 |
| 07-15 | +24 | 0 | +2 | +26 |
| 07-14 | -24 | 0 | +1 | -23 |
| 07-13 | -45 | 0 | 0 | -45 |
| 07-09 | +6 | 0 | -3 | +3 |
| 07-08 | -29 | 0 | +1 | -28 |
| 07-07 | +9 | 0 | 0 | +9 |
| 07-06 | -109 | 0 | -1 | -110 |
| 07-03 | +292 | 0 | 0 | +292 |
| 07-02 | +10 | 0 | +2 | +12 |
| 07-01 | +36 | 0 | +2 | +38 |
| 06-30 | +9 | 0 | 0 | +9 |
| 06-29 | +28 | 0 | -3 | +25 |
| 06-26 | -39 | 0 | -3 | -42 |
| 06-25 | -6 | 0 | +4 | -2 |
| 06-24 | -6 | 0 | 0 | -6 |
| 06-22 | -38 | 0 | -2 | -40 |
| 06-18 | -4 | 0 | +1 | -4 |
| 06-17 | -10 | 0 | +1 | -9 |
| 06-16 | +11 | 0 | +4 | +15 |
| 06-15 | +59 | 0 | 0 | +59 |
| 06-12 | +7 | 0 | 0 | +7 |
| 06-10 | +10 | 0 | 0 | +10 |
| 06-09 | -25 | 0 | -2 | -27 |
| 06-08 | -18 | 0 | +2 | -16 |
| 06-04 | +69 | 0 | -1 | +68 |
| 06-03 | +152 | 0 | 0 | +152 |
| 06-02 | +92 | 0 | -7 | +85 |
| 06-01 | +69 | 0 | +2 | +71 |
| 05-29 | +27 | 0 | +5 | +32 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/08 | 1267 萬 | +6.6% | +25.8% |
| 2026/07 | 1189 萬 | -16.7% | -4.1% |
| 2026/06 | 1428 萬 | +20.3% | +27.8% |
| 2026/05 | 1187 萬 | +21.7% | +18.4% |
| 2026/04 | 976 萬 | -1.0% | -0.8% |
| 2026/03 | 986 萬 | +6.9% | -21.4% |
| 2026/02 | 922 萬 | -40.2% | +5.0% |
| 2026/01 | 1544 萬 | +79.5% | +67.6% |
| 2025/12 | 860 萬 | -26.2% | -38.5% |
| 2025/11 | 1165 萬 | -9.7% | -14.1% |
| 2025/10 | 1290 萬 | -25.8% | +35.9% |
| 2025/09 | 1739 萬 | - | +10.9% |